Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Friborg

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Virology|May 7, 2002
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunizationBimal K Chakrabarti, Wing-pui Kong, Bei-yue Wu, et al.
Journal of Virology|June 1, 2007
X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavirHerbert E Klei, Kevin Kish, Pin-Fang M Lin, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2017
The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 proteaseMichael Bowsher, Sheldon Hiebert, Rongti Li, et al.
Plos One|June 10, 2016
A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma VirusesAmy K Sheaffer, Min S Lee, Huilin Qi, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Amy K Sheaffer, Jacques Friborg, et al.
Journal of Virology|September 13, 2003
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactionsQi Guo, Hsu-Tso Ho, Ira Dicker, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2016
Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virusAlan Xiangdong Wang, Jie Chen, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond DonorBarbara Zheng, Stanley V D'Andrea, Li-Qiang Sun, et al.
Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Virology|May 7, 2002
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunizationBimal K Chakrabarti, Wing-pui Kong, Bei-yue Wu, et al.
Journal of Virology|June 1, 2007
X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavirHerbert E Klei, Kevin Kish, Pin-Fang M Lin, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2017
The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 proteaseMichael Bowsher, Sheldon Hiebert, Rongti Li, et al.
Plos One|June 10, 2016
A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma VirusesAmy K Sheaffer, Min S Lee, Huilin Qi, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Amy K Sheaffer, Jacques Friborg, et al.
Journal of Virology|September 13, 2003
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactionsQi Guo, Hsu-Tso Ho, Ira Dicker, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2016
Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virusAlan Xiangdong Wang, Jie Chen, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond DonorBarbara Zheng, Stanley V D'Andrea, Li-Qiang Sun, et al.
Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Pageof 3